Hyperleptinemia has been shown to lead to the development of insulin resistance (the pathways of leptin and insulin cross), inhibition of lipid oxidation, and activation of lipogenesis by SREBP-1 in the liver (Jiménez-Cortegana et al., 2021). This evidence concerns the gene SREBF1 and Insulin resistance.